382 related articles for article (PubMed ID: 35429301)
1. The role of epigenetic modifications in Colorectal Cancer Metastasis.
Su R; Wu X; Tao L; Wang C
Clin Exp Metastasis; 2022 Aug; 39(4):521-539. PubMed ID: 35429301
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
[TBL] [Abstract][Full Text] [Related]
3. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
[TBL] [Abstract][Full Text] [Related]
4. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
5. The significance of DNA methylation profile in metastasis-related genes for the progression of colorectal cancer.
Tokarz P; Pawlowska E; Bialkowska-Warzecha J; Blasiak J
Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):79-87. PubMed ID: 28364795
[TBL] [Abstract][Full Text] [Related]
6. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics of colorectal cancer.
Migheli F; Migliore L
Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and its therapeutic potential in colorectal cancer.
Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
[TBL] [Abstract][Full Text] [Related]
10. Role of epigenetics in transformation of inflammation into colorectal cancer.
Yang ZH; Dang YQ; Ji G
World J Gastroenterol; 2019 Jun; 25(23):2863-2877. PubMed ID: 31249445
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
14. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation and chromatin modifiers in colorectal cancer.
Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis.
Li Q; Chen H
Epigenetics; 2011 Jul; 6(7):849-52. PubMed ID: 21758003
[TBL] [Abstract][Full Text] [Related]
18. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
Amirkhah R; Naderi-Meshkin H; Shah JS; Dunne PD; Schmitz U
Cells; 2019 Aug; 8(8):. PubMed ID: 31430887
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers in colorectal cancer: premises and prospects.
Zamani M; Hosseini SV; Mokarram P
Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
